# Zevalin

NDC: 72893-007
Generic name: ibritumomab tiuxetan
Labeler / Manufacturer: Acrotech Biopharma Inc
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Biologic License Application
Dosage form: KIT
Routes: —
Marketing started: 20020219

FDA application: BLA125019

## Active ingredients

—

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"72893-007"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=72893-007
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=25d367dc-da65-44c9-a844-1bf15339c285